CNBX Pharmaceuticals Inc. Liquidation Value Calculator
CNBX Pharmaceuticals Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 56 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$12,154 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$12,154 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$2.55M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
1.13B | shares | ||
Unmapped Tags (49)
| Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent | $43,530 | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $22.78M | USD | ||
| Assets Assets | $14,899 | USD | ||
| Assets Current AssetsCurrent | $14,899 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $1.80B | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $1.13B | shares | ||
| Common Stock Value CommonStockValue | $112,577 | USD | ||
| Convertible Notes Payable Current ConvertibleNotesPayableCurrent | $1.09M | USD | ||
| Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1 | $120,562 | USD | ||
| Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1 | $571.81M | shares | ||
| Deferred Compensation Equity DeferredCompensationEquity | $0 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $14,899 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $5.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Preferred Stock Value PreferredStockValue | $0 | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $0 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-25.43M | USD | ||
| Stockholders Equity StockholdersEquity | $-2.53M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $-2,957 | USD | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $0 | USD | ||
| Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables | $-581 | USD | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | $65,604 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $75,000 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-77,957 | USD | ||
| Proceeds From Short Term Debt ProceedsFromShortTermDebt | $75,000 | USD | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax | $0 | USD | ||
| Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax | $-157,817 | USD | ||
| Cost Of Revenue CostOfRevenue | $0 | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $0 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $0 | USD/shares | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $136,965 | USD | ||
| Gross Profit GrossProfit | $0 | USD | ||
| Interest Expense Debt InterestExpenseDebt | $13,675 | USD | ||
| Labor And Related Expense LaborAndRelatedExpense | $18,843 | USD | ||
| Net Income Loss NetIncomeLoss | $-157,817 | USD | ||
| Operating Expenses OperatingExpenses | $136,965 | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-136,965 | USD | ||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | $0 | USD | ||
| Other Nonoperating Income Expense OtherNonoperatingIncomeExpense | $-20,852 | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $2,745 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $0 | USD | ||
| Revenues Revenues | $0 | USD | ||
| Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent | $68,373 | USD | ||
| Number Of Operating Segments NumberOfOperatingSegments | $1 | Integer | ||
| Number Of Reportable Segments NumberOfReportableSegments | $1 | Integer | ||
| Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | $120,562 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.